Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 87.53% | -37.74% | 73.67% | -304.44% | -147.93% |
| Total Depreciation and Amortization | -12.96% | 1.43% | 10.00% | 5.77% | 8.41% |
| Total Amortization of Deferred Charges | -- | -38.75% | -47.08% | -47.45% | -- |
| Total Other Non-Cash Items | 3,283.87% | 163.69% | -111.01% | 115.32% | 164.32% |
| Change in Net Operating Assets | -206.10% | -86.07% | 109.44% | -81.49% | 151.59% |
| Cash from Operations | 192.28% | -55.54% | -215.33% | -158.88% | -10.90% |
| Capital Expenditure | 1.42% | 63.86% | 65.94% | 69.92% | 20.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 100.00% | -100.00% | -- |
| Cash from Investing | 80.82% | 57.13% | 67.34% | 47.65% | -444.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,676.47% | 99.66% | -2.63% | -2.59% | 9.63% |
| Issuance of Common Stock | -- | 211.35% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.21% | 27.85% | -389.61% | -100.00% | -248.86% |
| Cash from Financing | -1,027.06% | 99.23% | -1,119.65% | -772.81% | -775.00% |
| Foreign Exchange rate Adjustments | -58.90% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -36.48% | 89.57% | -628.14% | -231.93% | -181.41% |